1. Home
  2. AMST vs GLMD Comparison

AMST vs GLMD Comparison

Compare AMST & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • GLMD
  • Stock Information
  • Founded
  • AMST 2017
  • GLMD 2000
  • Country
  • AMST United States
  • GLMD Israel
  • Employees
  • AMST N/A
  • GLMD N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • GLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMST Technology
  • GLMD Health Care
  • Exchange
  • AMST Nasdaq
  • GLMD Nasdaq
  • Market Cap
  • AMST 7.4M
  • GLMD 5.9M
  • IPO Year
  • AMST 2020
  • GLMD 2014
  • Fundamental
  • Price
  • AMST $2.36
  • GLMD $2.80
  • Analyst Decision
  • AMST
  • GLMD
  • Analyst Count
  • AMST 0
  • GLMD 0
  • Target Price
  • AMST N/A
  • GLMD N/A
  • AVG Volume (30 Days)
  • AMST 18.3K
  • GLMD 66.9K
  • Earning Date
  • AMST 11-14-2024
  • GLMD 11-29-2024
  • Dividend Yield
  • AMST N/A
  • GLMD N/A
  • EPS Growth
  • AMST N/A
  • GLMD N/A
  • EPS
  • AMST N/A
  • GLMD N/A
  • Revenue
  • AMST $114,798.00
  • GLMD N/A
  • Revenue This Year
  • AMST N/A
  • GLMD N/A
  • Revenue Next Year
  • AMST N/A
  • GLMD N/A
  • P/E Ratio
  • AMST N/A
  • GLMD N/A
  • Revenue Growth
  • AMST N/A
  • GLMD N/A
  • 52 Week Low
  • AMST $1.72
  • GLMD $2.73
  • 52 Week High
  • AMST $4.34
  • GLMD $23.80
  • Technical
  • Relative Strength Index (RSI)
  • AMST 39.69
  • GLMD 37.59
  • Support Level
  • AMST $2.31
  • GLMD $2.84
  • Resistance Level
  • AMST $2.49
  • GLMD $3.05
  • Average True Range (ATR)
  • AMST 0.17
  • GLMD 0.24
  • MACD
  • AMST -0.05
  • GLMD 0.04
  • Stochastic Oscillator
  • AMST 7.25
  • GLMD 8.33

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Share on Social Networks: